These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18056788)

  • 41. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs.
    Moore MC; Satake S; Baranowski B; Hsieh PS; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E286-96. PubMed ID: 11788359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhalation of human insulin (exubera) augments the efficiency of muscle glucose uptake in vivo.
    Edgerton DS; Cherrington AD; Williams P; Neal DW; Scott M; Bowen L; Wilson W; Hobbs CH; Leach C; Kuo MC; Strack TR
    Diabetes; 2006 Dec; 55(12):3604-10. PubMed ID: 17130510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog.
    Edgerton DS; Cardin S; Neal D; Farmer B; Lautz M; Pan C; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E510-22. PubMed ID: 14644767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for a gut-brain axis used by glucagon-like peptide-1 to elicit hyperglycaemia in fish.
    Polakof S; Míguez JM; Soengas JL
    J Neuroendocrinol; 2011 Jun; 23(6):508-18. PubMed ID: 21564347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Basal hepatic glucose production is regulated by the portal vein insulin concentration.
    Sindelar DK; Chu CA; Venson P; Donahue EP; Neal DW; Cherrington AD
    Diabetes; 1998 Apr; 47(4):523-9. PubMed ID: 9568682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of glucagon-like peptide 1 on the hepatic glucose metabolism.
    D'Alessio D; Vahl T; Prigeon R
    Horm Metab Res; 2004; 36(11-12):837-41. PubMed ID: 15655716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia.
    DiCostanzo CA; Moore MC; Lautz M; Scott M; Farmer B; Everett CA; Still JG; Higgins A; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E46-52. PubMed ID: 15713685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
    Arakawa M; Ebato C; Mita T; Fujitani Y; Shimizu T; Watada H; Kawamori R; Hirose T
    Metabolism; 2008 Sep; 57(9):1299-306. PubMed ID: 18702958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic glucose autoregulation: responses to small, non-insulin-induced changes in arterial glucose.
    Camacho RC; Lacy DB; James FD; Coker RH; Wasserman DH
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E269-74. PubMed ID: 15053988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
    Rivera N; Everett-Grueter CA; Edgerton DS; Rodewald T; Neal DW; Nishimura E; Larsen MO; Jacobsen LO; Kristensen K; Brand CL; Cherrington AD
    J Pharmacol Exp Ther; 2007 May; 321(2):743-52. PubMed ID: 17308040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic glucose uptake rapidly decreases after removal of the portal signal in conscious dogs.
    Hsieh PS; Moore MC; Neal DW; Cherrington AD
    Am J Physiol; 1998 Dec; 275(6):E987-92. PubMed ID: 9843741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs.
    Moore MC; DiCostanzo CA; Dardevet D; Lautz M; Farmer B; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E556-63. PubMed ID: 15522992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog.
    Adkins BA; Myers SR; Hendrick GK; Stevenson RW; Williams PE; Cherrington AD
    J Clin Invest; 1987 Feb; 79(2):557-65. PubMed ID: 2879854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The diabetogenic effects of acute verapamil poisoning.
    Kline JA; Raymond RM; Schroeder JD; Watts JA
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):357-62. PubMed ID: 9266809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intraportal administration of neuropeptide Y and hepatic glucose metabolism.
    Nishizawa M; Shiota M; Moore MC; Gustavson SM; Neal DW; Cherrington AD
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1197-204. PubMed ID: 18234742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride.
    Basu A; Charkoudian N; Schrage W; Rizza RA; Basu R; Joyner MJ
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1289-95. PubMed ID: 17711996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of portal glucose delivery on glucose metabolism in conscious, unrestrained mice.
    Chueh FY; Malabanan C; McGuinness OP
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1206-11. PubMed ID: 16822956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor.
    Burcelin R; Da Costa A; Drucker D; Thorens B
    Diabetes; 2001 Aug; 50(8):1720-8. PubMed ID: 11473030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhalation of human insulin is associated with improved insulin action compared with subcutaneous injection and endogenous secretion in dogs.
    Edgerton DS; Stettler KM; Neal DW; Scott M; Bowen L; Wilson W; Hobbs CH; Leach C; Strack TR; Cherrington AD
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1258-64. PubMed ID: 16963622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.